Literature DB >> 24028275

FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile.

L Santa María1, A Pugin, M A Alliende, S Aliaga, B Curotto, T Aravena, H-T Tang, G Mendoza-Morales, R Hagerman, F Tassone.   

Abstract

Carriers of an FMR1 premutation allele (55-200 CGG repeats) often develop the neurodegenerative disorders, fragile X-associated tremor/ataxia syndrome (FXTAS). Neurological signs of FXTAS, parkinsonism and rapid onset of cognitive decline have not been reported in individuals with an unmethylated full mutation (FM). Here, we report a Chilean family affected with FXS, inherited from a parent carrier of an FMR1 unmethylated full mosaic allele, who presented with a fast progressing FXTAS. This case suggests that the definition of FXTAS may need to be broadened to not only include those with a premutation but also those with an expanded allele in FM range with a lack of methylation leading to elevated FMR1-mRNA expression levels and subsequent RNA toxicity.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  FXTAS; fragile X; parkinsonism; unmethylated full mutation

Mesh:

Substances:

Year:  2013        PMID: 24028275      PMCID: PMC4004716          DOI: 10.1111/cge.12278

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  26 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

2.  Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.

Authors:  F Tassone; R J Hagerman; D Z Loesch; A Lachiewicz; A K Taylor; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-09-18

3.  Intrafamilial variability in fragile X-associated tremor/ataxia syndrome.

Authors:  Nils Peters; Christoph Kamm; Friedrich Asmus; Elke Holinski-Feder; Eduard Kraft; Martin Dichgans; Roland Brüning; Thomas Gasser; Kai Bötzel
Journal:  Mov Disord       Date:  2006-01       Impact factor: 10.338

4.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.

Authors:  J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

5.  Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease.

Authors:  Andreea L Seritan; Danh V Nguyen; Sarah Tomaszewski Farias; Ladson Hinton; Jim Grigsby; James A Bourgeois; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

6.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

7.  Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers.

Authors:  Y Liu; T I Winarni; L Zhang; F Tassone; R J Hagerman
Journal:  Clin Genet       Date:  2012-10-17       Impact factor: 4.438

Review 8.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

9.  CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Flora Tassone; John Adams; Elizabeth M Berry-Kravis; Susannah S Cohen; Alfredo Brusco; Maureen A Leehey; Lexin Li; Randi J Hagerman; Paul J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  26 in total

Review 1.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

3.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

Review 4.  The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.

Authors:  Jim Grigsby
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

Review 5.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

Review 6.  Fragile X spectrum disorders.

Authors:  Reymundo Lozano; Carolina Alba Rosero; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 7.  Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions.

Authors:  Zhi-Dong Zhou; Joseph Jankovic; Tetsuo Ashizawa; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2022-01-12       Impact factor: 44.711

Review 8.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

Review 9.  The RNA-binding fragile-X mental retardation protein and its role beyond the brain.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Biophys Rev       Date:  2020-07-11

10.  Fragile X syndrome in a male with methylated premutation alleles and no detectable methylated full mutation alleles.

Authors:  Bruce Hayward; Inna Loutaev; Xiaohua Ding; Sarah L Nolin; Audrey Thurm; Karen Usdin; Carolyn B Smith
Journal:  Am J Med Genet A       Date:  2019-07-29       Impact factor: 2.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.